These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Modified Vaccinia Virus Ankara Can Induce Optimal CD8 Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596 [TBL] [Abstract][Full Text] [Related]
33. Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccines Efficiently Protect Cockatiels Against Parrot Bornavirus Infection and Proventricular Dilatation Disease. Rall I; Amann R; Malberg S; Herden C; Rubbenstroth D Viruses; 2019 Dec; 11(12):. PubMed ID: 31817690 [TBL] [Abstract][Full Text] [Related]
34. Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles. Kainulainen MH; Spengler JR; Welch SR; Coleman-McCray JD; Harmon JR; Scholte FEM; Goldsmith CS; Nichol ST; Albariño CG; Spiropoulou CF J Infect Dis; 2019 Sep; 220(8):1281-1289. PubMed ID: 31152662 [TBL] [Abstract][Full Text] [Related]
35. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. ter Meulen J; Badusche M; Kuhnt K; Doetze A; Satoguina J; Marti T; Loeliger C; Koulemou K; Koivogui L; Schmitz H; Fleischer B; Hoerauf A J Virol; 2000 Mar; 74(5):2186-92. PubMed ID: 10666248 [TBL] [Abstract][Full Text] [Related]
36. HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice. Jongwe TI; Chapman R; Douglass N; Chetty S; Chege G; Williamson AL PLoS One; 2016; 11(7):e0159141. PubMed ID: 27427967 [TBL] [Abstract][Full Text] [Related]
37. A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge. Salvato MS; Domi A; Guzmán-Cardozo C; Medina-Moreno S; Zapata JC; Hsu H; McCurley N; Basu R; Hauser M; Hellerstein M; Guirakhoo F Pathogens; 2019 Aug; 8(3):. PubMed ID: 31466243 [TBL] [Abstract][Full Text] [Related]
38. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. Hanke T; Samuel RV; Blanchard TJ; Neumann VC; Allen TM; Boyson JE; Sharpe SA; Cook N; Smith GL; Watkins DI; Cranage MP; McMichael AJ J Virol; 1999 Sep; 73(9):7524-32. PubMed ID: 10438842 [TBL] [Abstract][Full Text] [Related]
39. Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge. He Y; Meseda CA; Vassell RA; Merchlinsky M; Weir JP; Weiss CD Vaccine; 2010 Jan; 28(3):699-706. PubMed ID: 19887133 [TBL] [Abstract][Full Text] [Related]
40. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology. de Waal L; Wyatt LS; Yüksel S; van Amerongen G; Moss B; Niesters HG; Osterhaus AD; de Swart RL Vaccine; 2004 Feb; 22(8):923-6. PubMed ID: 15161069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]